TONY ESPOSITO, DIRECTOR OF QUALITY SYSTEMS
Tony Esposito brings more than 25 years of pharmaceutical industry experience with him to this role. He provides compliance leadership, ensuring GXP compliance across all BioMotiv projects and subsidiaries. He is responsible for developing and prioritizing audit strategy, leading regulatory authority inspections, vendor assessment/oversight and provide guidance/interpretation on GXP regulations, standards and quality systems.
Tony has broad clinical research and quality experience, across multiple therapeutic areas including immunology (gastrointestinal, dermatology and rheumatoid arthritis), neuroscience, cardiovascular, pulmonary, endocrinology, ophthalmology, oncology, and stem cells. Prior to joining BioMotiv, Tony spent the majority of his career at Janssen (Johnson & Johnson) as a leader of clinical quality for the immunology/biologics division (Centocor) and was responsible for quality strategy, management, and leadership across the global organization. He has held various roles in quality and clinical operations at Janssen (Johnson & Johnson), Bristol Myers-Squibb, Pharma Net (CRO), NYU Medical Center/Bellevue Hospital and Memorial Sloan-Kettering Cancer Center.
Tony has degrees in Psychology and English from Rutgers University.